Evidence map›Paper›PMID 39005958›Full record

ArticleInternational journal of nanomedicine2024

Designing Mesoporous Prussian Blue@zinc Phosphate Nanoparticles with Hierarchical Pores for Varisized Guest Delivery and Photothermally-Augmented Chemo-Starvation Therapy.

Yuan Yuan, Mingyi Hou, Xiaoning Song, Xintao Yao, Xuerui Wang, Xiangjun Chen, Shengnan Li

Abstract read
In one paragraph

Article in International journal of nanomedicine, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Yuan Yuan *School of Chemical Engineering and Technology, Hebei University of Technology, Tianjin, 300401, People's Republic of China.
Mingyi Hou *School of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, Yantai, 264003, People's Republic of China.
Xiaoning SongSchool of Chemical Engineering and Technology, Hebei University of Technology, Tianjin, 300401, People's Republic of China.
Xintao YaoSchool of Chemical Engineering and Technology, Hebei University of Technology, Tianjin, 300401, People's Republic of China.
Xuerui WangSchool of Chemical Engineering and Technology, Hebei University of Technology, Tianjin, 300401, People's Republic of China.
Xiangjun ChenSchool of Pharmacy, Shandong New Drug Loading & Release Technology and Preparation Engineering Laboratory, Binzhou Medical University, Yantai, 264003, People's Republic of China.
Shengnan LiSchool of Chemical Engineering and Technology, Hebei University of Technology, Tianjin, 300401, People's Republic of China.ORCID 0000-0001-9166-7924

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Background: With the rapid development of nanotechnology, constructing a multifunctional nanoplatform that can deliver various therapeutic agents in different departments and respond to endogenous/exogenous stimuli for multimodal synergistic cancer therapy remains a major challenge to address the inherent limitations of chemotherapy. Methods: Herein, we synthesized hollow mesoporous Prussian Blue@zinc phosphate nanoparticles to load glucose oxidase (GOx) and DOX (designed as HMPB-GOx@ZnP-DOX NPs) in the non-identical pore structures of their HMPB core and ZnP shell, respectively, for photothermally augmented chemo-starvation therapy. Results: The ZnP shell coated on the HMPB core, in addition to providing space to load DOX for chemotherapy, could also serve as a gatekeeper to protect GOx from premature leakage and inactivation before reaching the tumor site because of its degradation characteristics under mild acidic conditions. Moreover, the loaded GOx can initiate starvation therapy by catalyzing glucose oxidation while causing an upgradation of acidity and H Conclusion: HMPB-GOx@ZnP-DOX NPs can be employed as potential theranostic agents that incorporate multiple therapeutic modes to efficiently inhibit tumors.

Indexed as

DoxorubicinFerrocyanidesGlucose OxidasePhosphatesPhotothermal TherapyZinc CompoundsAnimalsCell Line, TumorDrug CarriersDrug Delivery SystemsDrug LiberationHumansMiceMice, Inbred BALB CNanoparticlesNeoplasmsDoxorubicinDrug Carriersferric ferrocyanideFerrocyanidesGlucose OxidasePhosphatesZinc Compoundszinc phosphatechemotherapyco-delivery systemglucose oxidasephotothermal therapyPrussian Blue

Identifiers

PMID39005958
PMCPMC11244623

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.